Table 1.

Cell numbers and populations of lymphocytes in the spleen of mice recipients of bone marrow transplantation (BMT) 14 and 28 days after BMT

Mouse group Day No. of cells (×107) Cell population (% of total spleen cells)
CD3 CD19 CD4 CD134+CD4 CD8H-2Kb+d+/H-2Kb+d
BDF1 (control)   7.5 ± 1.6  52.1 ± 7.4 36.4 ± 8.1  35.6 ± 7.2  3.2 ± 0.8 17.8 ± 4.2  100/0  
B6 TCD-BM  14 28 6.5 ± 1.2 6.8 ± 1.4  14.9 ± 2.2 15.2 ± 3.5  44.2 ± 8.8 47.0 ± 7.9  11.5 ± 2.4 11.9 ± 2.2  4.1 ± 1.9 4.2 ± 1.2  2.4 ± 0.8 2.6 ± 1.1  15.2 ± 2.4/83.8 ± 4.3 12.8 ± 3.1/86.2 ± 5.1  
B6 BMS + rat IgG  14 28 1.2 ± 0.6 0.62 ± 0.2  68.6 ± 8.8 79.2 ± 8.4  6.4 ± 3.5 8.9 ± 3.6  30.1 ± 5.4 46.3 ± 6.1  16.2 ± 2.4 24.5 ± 3.3  31.7 ± 5.1 25.1 ± 4.5  1.4 ± 0.8/98.5 ± 1.1 6.3 ± 2.2/93.2 ± 4.5  
B6 BMS + anti-CD134L mAb  14 28  1.0 ± 0.3 1.3 ± 0.2  32.1 ± 4.1 48.4 ± 5.3  29.8 ± 3.5 20.5 ± 4.6  14.1 ± 2.7 25.5 ± 4.3  4.6 ± 2.1 8.8 ± 3.1  21.5 ± 3.5 26.2 ± 3.8  1.5 ± 0.8/97.9 ± 2.1 1.8 ± 1.1/97.1 ± 3.1 
Mouse group Day No. of cells (×107) Cell population (% of total spleen cells)
CD3 CD19 CD4 CD134+CD4 CD8H-2Kb+d+/H-2Kb+d
BDF1 (control)   7.5 ± 1.6  52.1 ± 7.4 36.4 ± 8.1  35.6 ± 7.2  3.2 ± 0.8 17.8 ± 4.2  100/0  
B6 TCD-BM  14 28 6.5 ± 1.2 6.8 ± 1.4  14.9 ± 2.2 15.2 ± 3.5  44.2 ± 8.8 47.0 ± 7.9  11.5 ± 2.4 11.9 ± 2.2  4.1 ± 1.9 4.2 ± 1.2  2.4 ± 0.8 2.6 ± 1.1  15.2 ± 2.4/83.8 ± 4.3 12.8 ± 3.1/86.2 ± 5.1  
B6 BMS + rat IgG  14 28 1.2 ± 0.6 0.62 ± 0.2  68.6 ± 8.8 79.2 ± 8.4  6.4 ± 3.5 8.9 ± 3.6  30.1 ± 5.4 46.3 ± 6.1  16.2 ± 2.4 24.5 ± 3.3  31.7 ± 5.1 25.1 ± 4.5  1.4 ± 0.8/98.5 ± 1.1 6.3 ± 2.2/93.2 ± 4.5  
B6 BMS + anti-CD134L mAb  14 28  1.0 ± 0.3 1.3 ± 0.2  32.1 ± 4.1 48.4 ± 5.3  29.8 ± 3.5 20.5 ± 4.6  14.1 ± 2.7 25.5 ± 4.3  4.6 ± 2.1 8.8 ± 3.1  21.5 ± 3.5 26.2 ± 3.8  1.5 ± 0.8/97.9 ± 2.1 1.8 ± 1.1/97.1 ± 3.1 

Phenotypic analysis was performed with use of fluorescence-activated cell sorter. Plus-minus values are the mean ± SD for 3 mice in each group. TCD-BM indicates T-cell-depleted bone marrow; BMS, bone marrow cells and spleen cells; and mAb, monoclonal antibody.

or Create an Account

Close Modal
Close Modal